Literature DB >> 32898444

Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease.

Edward T Morgan1, Cene Skubic2, Choon-Myung Lee1, Kaja Blagotinšek Cokan2, Damjana Rozman2.   

Abstract

Many hepatic cytochrome P450 enzymes and their associated drug metabolizing activities are down-regulated in disease states, and much of this has been associated with inflammatory cytokines and their signaling pathways. One such pathway is the induction of inducible nitric oxide synthase (NOS2) and generation of nitric oxide (NO) in many tissues and cells including the liver and hepatocytes. Experiments in the 1990s demonstrated that NO could bind to and inhibit P450 enzymes, and suggested that inhibition of NOS could attenuate, and NO generation could mimic, the down-regulation by inflammatory stimuli of not only P450 catalytic activities but also of mRNA expression and protein levels of certain P450 enzymes. This review will summarize and examine the evidence that NO functionally inhibits and down-regulates P450 enzymes in vivo and in vitro, with a particular focus on the mechanisms by which these effects are achieved.

Entities:  

Keywords:  Cytochrome P450; enzyme inhibition; gene transcription; inflammation; nitric oxide; protein degradation

Year:  2020        PMID: 32898444      PMCID: PMC7709541          DOI: 10.1080/03602532.2020.1817061

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  144 in total

1.  Proteolytic degradation of tyrosine nitrated proteins.

Authors:  J M Souza; I Choi; Q Chen; M Weisse; E Daikhin; M Yudkoff; M Obin; J Ara; J Horwitz; H Ischiropoulos
Journal:  Arch Biochem Biophys       Date:  2000-08-15       Impact factor: 4.013

Review 2.  Nitric oxide: a physiologic messenger molecule.

Authors:  D S Bredt; S H Snyder
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

3.  S-nitrosylation in the regulation of gene transcription.

Authors:  Yonggang Sha; Harvey E Marshall
Journal:  Biochim Biophys Acta       Date:  2011-05-24

4.  "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms.

Authors:  L K Keefer; R W Nims; K M Davies; D A Wink
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

5.  Irreversible inhibition of cytochrome P450 by nitric oxide.

Authors:  Y Minamiyama; S Takemura; S Imaoka; Y Funae; Y Tanimoto; M Inoue
Journal:  J Pharmacol Exp Ther       Date:  1997-12       Impact factor: 4.030

6.  Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin.

Authors:  C M Müller; A Scierka; R L Stiller; Y M Kim; D R Cook; J R Lancaster; C W Buffington; W D Watkins
Journal:  Anesthesiology       Date:  1996-06       Impact factor: 7.892

7.  Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent.

Authors:  E Siewert; R Bort; R Kluge; P C Heinrich; J Castell; R Jover
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

8.  Targets of nitric oxide in a mouse model of liver inflammation by Corynebacterium parvum.

Authors:  W Chamulitrat; S J Jordan; R P Mason; A L Litton; J G Wilson; E R Wood; G Wolberg; L Molina y Vedia
Journal:  Arch Biochem Biophys       Date:  1995-01-10       Impact factor: 4.013

9.  Characterization of the physiological turnover of native and inactivated cytochromes P450 3A in cultured rat hepatocytes: a role for the cytosolic AAA ATPase p97?

Authors:  Saadia Faouzi; Katalin F Medzihradszky; Colleen Hefner; Jacquelyn J Maher; Maria Almira Correia
Journal:  Biochemistry       Date:  2007-06-06       Impact factor: 3.162

10.  Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent.

Authors:  D A Wink; Y Osawa; J F Darbyshire; C R Jones; S C Eshenaur; R W Nims
Journal:  Arch Biochem Biophys       Date:  1993-01       Impact factor: 4.013

View more
  5 in total

1.  Monooxygenase System and NO Metabolism in Liver Microsomes of Rats with Toxic Hepatitis and the Effect of Sesquiterpene Lactones.

Authors:  N V Tursunova; V N Syrov; Z A Khushbaktova; Yu V Tornuev; M G Klinnikova
Journal:  Bull Exp Biol Med       Date:  2021-12-02       Impact factor: 0.804

Review 2.  Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics.

Authors:  Laura M de Jong; Wim Jiskoot; Jesse J Swen; Martijn L Manson
Journal:  Genes (Basel)       Date:  2020-12-16       Impact factor: 4.096

3.  Studies on CYP3A activity during the menstrual cycle as measured by urinary 6β-hydroxycortisol/cortisol.

Authors:  Helena Bergström; Anna Lindahl; Anna Warnqvist; Ulf Diczfalusy; Lena Ekström; Linda Björkhem-Bergman
Journal:  Pharmacol Res Perspect       Date:  2021-12

Review 4.  Cytochrome P450 Enzymes and Drug Metabolism in Humans.

Authors:  Mingzhe Zhao; Jingsong Ma; Mo Li; Yingtian Zhang; Bixuan Jiang; Xianglong Zhao; Cong Huai; Lu Shen; Na Zhang; Lin He; Shengying Qin
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

5.  Anti-inflammatory Effect of a Novel Pectin Polysaccharide From Rubus chingii Hu on Colitis Mice.

Authors:  Yuanfang Kong; Yulong Hu; Jieming Li; Juntao Cai; Yuanhao Qiu; Chunhong Dong
Journal:  Front Nutr       Date:  2022-04-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.